Barclays’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-25,000
Closed -$2.88M 7516
2018
Q1
$2.88M Buy
+25,000
New +$2.66M ﹤0.01% 2104

Other funds holding LOXO

Barclays's LOXO Position: Q1 2019 in Review

Barclays sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 7,699 shares — an estimated $1.08M sold.

Barclays first reported a position in LOXO in Q4 2014 and held it in 15 quarters. The position peaked at $4.41M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Barclays reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 7,699 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.08M.
  • Barclays first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 15 quarters.
  • Barclays's Loxo Oncology, Inc position peaked at $4.41M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.